Sign in
4/A

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-054741

Options or other derivatives

  • Director acquired 23,649 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SATO VICKI L Director 2020-05-21 Grant or award · Stock Option (Right to Buy) +23,649 23,649 D
Loading xslF345X03/doc4a.xml…